When was MCRA founded?

MCRA was founded in 2004 and raised its 1st funding round 14 years after it was founded.

Where is MCRA located?

MCRA is headquartered in New York City, United States. It is registered at Rīga, Tērbatas iela 30.

How many employees does MCRA have?

As of Aug 31, 2026, the latest employee count at MCRA is 252.

Is MCRA a funded company?

MCRA is a funded company, having raised a total of $***** in its 1st and only funding round, a Conventional Debt round on Jan 24, 2018.

When was the latest funding round of MCRA?

MCRA's latest funding was a $***** Conventional Debt round on Jan 24, 2018, with participation from 1 investor.

Where does MCRA rank among its competitors?

MCRA ranks 10th amongst 209 active competitors, of which 5 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was PharmAla Biotech, which secured $1.09M in Dec, 2024.

Who are the top competitors of MCRA?

MCRA's top competitors include Vasta Global, PharmAla Biotech and S-Cubed. Among them, PharmAla Biotech secured the most recent funding round in December, 2024.

MCRA - 2026 Company Profile, Funding & Competitors

MCRA is a funded company based in New York City (United States), founded in 2004. It operates as a Provider of regulatory, quality assurance and market access services to biopharma sector. MCRA has raised an undisclosed amount in funding. The company has 209 active competitors, including 5 funded and 15 that have exited. Its top competitors include companies like Vasta Global, PharmAla Biotech and S-Cubed.

Company Details

Website: www.mcra.com/
Social
Email ID: *****@mcra.com
Phone Number: +1 **********
Registered Address: Rīga, Tērbatas iela 30

Key Metrics

Founded Year

2004

Location

New York City, United States

Stage

Funding Raised

Latest Funding Round

Conventional Debt, Jan 24, 2018, $*****

Investors

Caltius Capital Management & 1 more

Ranked

10^th among 209 active competitors

Employee Count

252 as on Aug 31, 2026

Investment & Acquisitions

Vorpal Technologies

Similar Companies

Vasta Global & 250 more

View MCRA's full profile

MCRA is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MCRA, LLC CIN: 32077536038 , United States, Active		-	-	-
MCRA CIN: 40203039070 , Latvia, Active	Dec 16, 2016	€1M - €10M (As on Dec 31, 2024)	25 (As on Dec 31, 2022)	-

MCRA has raised funding over 1 round. Its latest funding round was a Conventional Debt round on Jan 24, 2018 for $*****. 1 investor participated in its latest round. MCRA has 2 institutional investors.

Here is the list of recent funding rounds of MCRA:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 24, 2018	6173701	Conventional Debt	5690179	7571399	9333680	3342930

Access funding benchmarks and valuations. Sign up today!

View details of MCRA's funding rounds and investors

MCRA's employee count trend

MCRA has 252 employees as of Aug 26. Here is MCRA's employee count trend over the years:

Uncover MCRA's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MCRA include Vasta Global, PharmAla Biotech and S-Cubed. Here is the list of Top 10 competitors of MCRA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Vasta Global 2010, Mumbai (India), Acquired	Offers clinical research consulting	-	-	57/100
2nd	PharmAla Biotech 2021, Toronto (Canada), Public	Provider of biomanufacturing, regulatory, and financial services	-	-	43/100
3rd	S-Cubed 2007, Copenhagen (Denmark), Acquired	Clinical development consultancy services in areas such as biometrics, CDISC, and regulatory affairs	-	-	42/100
4th	Pharmefex 2014, Bellevue (United States), Unfunded	CMC consulting for biologics, cell, and gene therapies	-	-	42/100
5th	Blue Matter Consulting 2012, San Francisco (United States), Late Stage	Provider of consulting services focused for clinical drug development	-	Baird Capital	38/100
6th	Biomapas 2001, Kaunas (Lithuania), Unfunded	Manufacturer of clinical research for medical devices	-	Carbyne Equity Partners	38/100
7th	TransCelerate BioPharma 2012, Conshohocken (United States), Unfunded	Provider of clinical development consulting services	-	-	38/100
8th	Cerveau Technologies 2015, Boston (United States), Acquired	Innovating PET imaging agents for Alzheimer's disease research and diagnostics	-	-	36/100
9th	Orchestra Life Sciences 2021, Chesterfield (United States), Unfunded	Provider of technical consultancy for cancer and rare disease therapies	-	-	36/100
10th	MCRA 2004, New York City (United States), Funding Raised	Provider of regulatory, quality assurance and market access services to biopharma sector	-	Caltius Capital Management, Viscogliosi Brothers	35/100